DCFGX
Price
$28.79
Change
-$1.80 (-5.88%)
Updated
Apr 3 closing price
Net Assets
187.51M
GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
Ad is loading...

DCFGX vs GFACX

Header iconDCFGX vs GFACX Comparison
Open Charts DCFGX vs GFACXBanner chart's image
Dunham Focused Large Cap Growth C
Price$28.79
Change-$1.80 (-5.88%)
VolumeN/A
Net Assets187.51M
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
DCFGX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DCFGX vs. GFACX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DCFGX is a StrongBuy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 280B vs. DCFGX (188M). DCFGX (0.00) and GFACX (0.00) have matching dividends . DCFGX was incepted earlier than GFACX: DCFGX (13 years) vs GFACX (24 years). DCFGX (2.23) is less costly to investors than GFACX (1.36). GFACX is a more actively managed with annual turnover of: 25.00 vs. DCFGX (11.00). GFACX has a lower initial minimum investment than DCFGX: GFACX (250) vs DCFGX (5000). GFACX annual gain was more profitable for investors over the last year : -1.75 vs. DCFGX (-14.39). GFACX (59.73) and DCFGX (57.68) have equivalent 5 years return.
DCFGXGFACXDCFGX / GFACX
Total Expense Ratio2.231.36164%
Annual Report Gross Expense Ratio2.231.36164%
Fund Existence13 years24 years-
Gain YTD-10.608-5.003212%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net Assets188M280B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-14.39-1.75821%
Returns for 3 years0.820.63131%
Returns for 5 years57.6859.7397%
Returns for 10 years96.7244.46218%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences